Thymosin Alpha 1 is a synthetic peptide derived from thymus gland proteins, extensively studied for its potential immunomodulatory properties in laboratory settings. Laboratory research involving Thymosin Alpha 1 investigates its effects on immune response regulation, modulation of cytokine production, and enhancement of T-cell function. Studies indicate Thymosin Alpha 1 may influence immune system function and inflammation pathways.

Scientific investigations continue to explore Thymosin Alpha 1’s potential impacts on immune modulation, antiviral activities, and inflammatory responses within controlled laboratory environments.

Important Notice: This product is intended strictly for research purposes only. It is not approved by the FDA and is not intended for human or animal consumption, nor for diagnostic, therapeutic, or clinical applications. Usage of Thymosin Alpha 1 outside laboratory research settings violates sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. §§ 355(a) and 331(d).

Product Specifications:

• Purity: ≥99% (HPLC verified)
• Formulation: Lyophilized powder
• Molecular Formula: C₁₂₉H₂₁₅N₃₃O₅₅
• Molecular Weight: 3108.3 g/mol
• CAS Number: 62304-98-7

Source: PubChem